Amino.Desk

Adamax

Updated Nov 17, 2026 · Clinical review: pending

Adamax is a derivative of Semax with two additions: a cap on one end and a cage-shaped carbon group called adamantane on the other. It is sold as the most potent Semax variant. It is also the least studied.

What it is

The adamantane group makes the peptide more fat-soluble, which is meant to help it cross into the brain and last longer. The same trick is used in P21.

What the evidence shows

No human trial of Adamax has been published. The reference sources we read agree that the evidence is animal and cell work at best, and that almost every claim about Adamax is extrapolated from Semax data.

A longer-lasting, more brain-penetrating version of a peptide is a different drug. It needs its own evidence.

Legal status

Reported dosing

We do not publish a protocol for this compound.

No dose has been established for this modified version. Dosing on seller pages is borrowed from the parent peptide or invented.

Safety

Common questions

What is Adamax?

A Semax derivative with an acetyl cap and an adamantane group, sold as a nootropic.

Has Adamax been tested in humans?

No published human trial exists.

Is Adamax better than Semax?

That is the marketing claim. It has not been tested.

Ask an AI about this page

Opens the assistant with a question about this page already typed in. You can edit it before sending.

Ask ChatGPTAsk ClaudeAsk Perplexity

These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.

Sources

Free field guide

Forty peptides and GLP-1s: who can legally get what, how strong the evidence is, and what to check before you pay. Plus one short email a week on what changed.

Leave at any time. We do not sell or share your address. Privacy